Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer

Green tea epigallocatechin-3-gallate (EGCG): A promising therapeutic agent for oral cancer

Saved in:

Bibliographic Details
Main Authors:	Saravanan Sekaran, Dhanraj Ganapathy, Pitchiah Sivaperumal
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024000451
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Green Tea Polyphenol Epigallocatechin Gallate Interactions with Copper-Serum Albumin
by: Meiling Fu, et al.
Published: (2025-01-01)

Epigallocatechin gallate (EGCG) modulates senescent endothelial cell-monocyte communication in age-related vascular inflammation
by: Sarvatit Patel, et al.
Published: (2025-01-01)

Pyrotinib: A promising therapeutic prospect for treating metastatic salivary gland cancer
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Therapeutic effects of epigallocatechin and epigallocatechin gallate on the allergic reaction of αs1-casein sensitized mice
by: Qianqian Zhang, et al.
Published: (2023-05-01)

Development and Validation of Near-Infrared Methods for the Quantitation of Caffeine, Epigallocatechin-3-gallate, and Moisture in Green Tea Production
by: Shengsheng Zhang, et al.
Published: (2021-01-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

Effect of epigallocatechin-3-gallate (EGCG) on cognitive functioning and the expression of APP and BDNF in the hippocampus of rats with streptozotocin -induced Alzheimer-like disease
by: Farnaz Ghayour Babaei, et al.
Published: (2025-03-01)

Stress-Relieving Effects of Japanese Green Tea: Evaluation Using the Molar Ratio of Caffeine and Epigallocatechin Gallate to Theanine and Arginine as an Indicator
by: Keiko Unno, et al.
Published: (2025-01-01)

Exploring FBXO43 as a potential therapeutic target: Implications for oral cancer progression
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Scleraxis (SCX): A novel therapeutic target in the malignant transformation of oral potentially malignant disorders
by: Bharathi Selvaraj, et al.
Published: (2024-06-01)

miR-1266-5p as a prognostic marker and miR-1255-5p/DAB2IP axis a therapeutic target in malignant transformation of oral submucous fibrosis
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Epigallocatechin-3-gallate inhibits the collagen accumulation of oral submucous fibrosis induced by arecoline
by: Ge Gao, et al.
Published: (2025-01-01)

Neuroprotective Activity of (-)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity
by: Jin-Biao Liu, et al.
Published: (2016-01-01)

Universal Repository for patients with oral cancer and oral premalignant lesions (UROC)
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Tumor-grafted chorioallantoic membrane model: A versatile approach to study head and neck squamous cell carcinoma physiopathology and therapeutics testing
by: Saravanan Sekaran, et al.
Published: (2024-06-01)

Intracellular microbiome in oral cancer progression
by: Dhanraj Ganapathy, et al.
Published: (2024-06-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)

Regional CAR T-cell therapy advancements for salivary gland tumors: Enhancing treatment precision and efficacy through regionalized cellular immunotherapy
by: Kannan Kamala, et al.
Published: (2024-06-01)

In vivo human skin penetration of (–)-epigallocatechin-3-gallate from topical formulations
by: Scalia Santo, et al.
Published: (2014-06-01)

Genetically modified virus for oral squamous cell carcinoma therapeutics
by: Pitchiah Sivaperumal, et al.
Published: (2024-03-01)

Local Administration of (−)-Epigallocatechin-3-Gallate as a Local Anesthetic Agent Inhibits the Excitability of Rat Nociceptive Primary Sensory Neurons
by: Syogo Utugi, et al.
Published: (2025-01-01)

Repurposing metformin: Can it revolutionize oral cancer treatment as a neoadjuvant therapeutic agent?
by: Deepavalli Arumuganainar, et al.
Published: (2024-09-01)

Repurposing Amlexanox to treat head and neck cancers: Increasing neoantigen expression to facilitate immunotherapy
by: Saravanan Sekaran, et al.
Published: (2024-06-01)

Faster healing through marine collagen-enriched skin grafts: A novel approach for oral wound recovery
by: Kannan Kamala, et al.
Published: (2024-06-01)

(−)-Epigallocatechin-3-Gallate and Quercetin Inhibit Quiescin Sulfhydryl Oxidase 1 Secretion from Hepatocellular Carcinoma Cells
by: Lumin Yang, et al.
Published: (2025-01-01)

SYNERGISTIC EFFECT OF QUERCETIN AND EPIGALLOCATECHIN-3-GALLATE AS AGENTS TO PREVENT CONNECTIVE TISSUE DISINTEGRATION IN THE PERIODONTIUM OF RATS UNDER SYSTEMIC AND LOCAL ADMINISTRATION OF LIPOPOLISACCHARIDE OF SALMONELLA TYPHI
by: A.M. Yelins’ka, et al.
Published: (2019-12-01)

The Safety and Efficacy of Dietary Epigallocatechin Gallate Supplementation for the Management of Obesity and Non-Alcoholic Fatty Liver Disease: Recent Updates
by: Ruike Yan, et al.
Published: (2025-01-01)

(-)-Epigallocatechin Gallate Reduces Platelet-Derived Growth Factor-BB-Stimulated Interleukin-6 Synthesis in Osteoblasts: Suppression of SAPK/JNK
by: Shinji Takai, et al.
Published: (2008-01-01)

Increasing the neoantigen expression by nonsense mediated mRNA decay inhibitors: An effective therapeutic approach in oral cancer?
by: Saravanan Sekaran
Published: (2024-06-01)

Construction of Pickering Double Emulsions Based on Xanthan Gum/Lysozyme Nanoparticles: Structure, Stability, and Co-Encapsulation of Epigallocatechin Gallate and β-Carotene
by: Yongpeng Yin, et al.
Published: (2025-01-01)

Epigallocatechin-3-gallate Protects against Hydrogen Peroxide-Induced Inhibition of Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells
by: Dawei Wang, et al.
Published: (2016-01-01)

Early diagnosis and rapid detection of TP53 mutation by REAL-TIME PCR in oral cancer
by: Smitha Nair, et al.
Published: (2024-09-01)

Comment on “Unlocking the therapeutic potential of microalgal astaxanthin a super antioxidant in oral cancer and associated ailments”
by: Antonyraj Matharasi Perianaika Anahas, et al.
Published: (2024-09-01)

Resveratrol—A Promising Therapeutic Agent with Problematic Properties
by: Lyubomira Radeva, et al.
Published: (2025-01-01)

Extraction of Keratin degrading enzyme from marine Actinobacteria of Nocardia sp and their antibacterial potential against oral pathogens
by: Haripriya Arun Subash, et al.
Published: (2024-03-01)

Oral microbiota dysbiosis and its association with oral squamous cell carcinoma: Implications for early detection and preventive strategies
by: Bharathi Selvaraj, et al.
Published: (2024-06-01)

Anti-Apoptosis Effects of Green Tea in Diagnostic and Therapeutic Doses of Ionizing Radiation
by: Najmeh Anbiaee, et al.
Published: (2024-07-01)

Transforming oral cancer care: The promise of deep learning in diagnosis
by: Durairaj Varalakshmi, et al.
Published: (2024-06-01)

Successful Treatment of Facial Acne Fulminans: Antimicrobial Agents and Oral Prednisolone as Promising Regimes
by: Amir Hossein Siadat, et al.
Published: (2017-01-01)

Formation of composite hydrogel of carboxymethyl konjac glucomannan/gelatin for sustained release of EGCG
by: Lin Wang, et al.
Published: (2022-09-01)